Case Study: Global Pharmaceutical Company cuts submission timelines by two-thirds with North Highland

Global Pharmaceutical Company cuts submission timelines by 67% with North Highland

A global pharmaceutical company faced a competitive disadvantage as its 24-week timeline to submit new therapies to health authorities was significantly slower than leading competitors. This delay caused them to lose patent rights and over $100M in revenue on a high-value therapy. The root causes included fragmented data across over 15 systems and a heavily manual process requiring 40+ full-time employees per submission. They partnered with North Highland to launch the Hyper Acceleration program to cut timelines to 8 weeks.

North Highland provided transformation leadership through program, project, and change management. The solution involved embedding into workstreams, automating clinical reporting, and streamlining the technology ecosystem. As a result, North Highland helped the client cut submission timelines by 67%, from 24 weeks down to 8, potentially unlocking $100M in value per submission. They also built enterprise-wide capability, enabling the client to sustain the improvements and replicate the framework across other programs.